Nutrition and Micronutrients in Cancer Patients Positive for COVID-19

Abstract

Nutrition is an important component of human health that influences the immune response, especially in those who are at risk of cancer. It is critical in the COVID-19 era to respond to cancer in a more coordinated and timely manner. So far, there are only a few systematic studies on the increased prevalence of COVID-19 or SARS-CoV2 symptomatic or asymptomatic infections in cancer patients with no comprehensive care plan. The goal of this research is to learn more about the function of diet in cancer patients with in COVID-19 period. The importance of diet in the predisposition, prevention, and management of COVID-19 in cancer patients, as well as the role of dietary supplementation with vitamins or minerals, and microbiota in the COVID-19 period, was discussed in this study. The results might aid in the development of nutritional maintenance and complication control guidelines for all patients with cancer during the continuing COVID-19 pandemic.

Keywords

• COVID-19
• Nutrition
• Cancer
• Cancer Nutrition
• Micronutrients

References

1. World Health Organization. 2020. http://www.emro.who.int/nutrition/news/nutrition-advice-for-adults-during-the-covid-19-outbreak.html
2. Chen J, Lu H, Melino G, et al. COVID-19 infection: the China and Italy perspectives. Cell Death Dis. 2020;11(6):438. doi:10.1038/s41419-020-2603-0
3. World Health Organization, Origin of SARS-CoV-2. 2020. (https://apps.who.int/iris/bitstream/handle/10665/332197/WHO-2019-nCoV-FAQ-Virus_origin-2020.1-eng.pdf)
4. Tian J, Yuan X, Xiao J, et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. The Lancet. Oncology. 2020;21(7):893–903. https://doi.org/10.1016/S1470-2045(20)30309-0
5. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet. Oncology. 2020;21(3):335–337. https://doi.org/10.1016/S1470-2045(20)30096-6
6. Assi T, Ibrahim N, K Abboud RM, et al. The management of patients with metastatic prostate cancer during the COVID-19 pandemic. Future Oncology. 2020;16(20):1455–1461. https://doi.org/10.2217/fon-2020-0361
7. Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of oncology: official journal of the European Society for Medical Oncology. 2020;31(7):894–901. https://doi.org/10.1016/j.annonc.2020.03.296
8. Carreira H, Strongman H, Peppa M, et al. Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: A matched cohort study using linked English electronic health records data, EClinicalMedicine. 2020;29-30:100656 https://doi.org/10.1016/j.eclinm.2020.100656

9. Yigenoglu TN, Ata N, Altuntas F, et al. The outcome of COVID-19 in patients with hematological malignancy. Journal of medical virology. 2021;93(2):1099–1104. https://doi.org/10.1002/jmv.26404
10. Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881–2892. https://doi.org/10.1182/blood.2020008824
11. Lee LYW, Cazier JB, Starkey T, et al. UK Coronavirus Cancer Monitoring Project Team. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020;21(10):1309-1316. https://doi.org/10.1016/S1470-2045(20)30442-3.
12. Tian J, Yuan X, Xiao J, et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020.
13. Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020.
14. Kalinsky K, Accordino MK, Hosi K, et al. Characteristics and outcomes of patients with breast cancer diagnosed with Nutrition and Cancer 11 SARS-Cov-2 infection at an academic center in New York City. Breast Cancer Res Treat. 2020;182(1):239– 242. doi:10.1007/s10549-020-05667-6
15. Vuagnat P, Frelaut M, Ramtohul T, et al. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area. Breast Cancer Res. 2020;22(1):55. doi:10.1186/s13058-020-01293-8
16. Aslam MF, Majeed S, Aslam S, et al. Vitamins: key role players in boosting up immune response, A mini review. Vitam Miner. 2017;6:153.
17. Carr AC, Rowe S. The emerging role of vitamin C in the prevention and treatment of COVID-19. Nutrients. 2020;12(11):3286. doi:10.3390/nu12113286 Haug A, Brand-Miller JC, Christophersen OA, et al. A food “lifeboat”: food and nutrition considerations in the event of a pandemic or other catastrophe. Med J Aust. 2007;187(11-12):674– 676. doi:10.5694/j.1326-5377.2007.tb01471.x
18. Arayici M, Yucel U, Ocek Z. Knowledge and Attitudes of Ege University Midwifery, Nutrition-Dietetic, and Nursing Students About Natural Functional Foods. Journal of Basic and Clinical Health Sciences. 2020;4(3):364-370. doi:10.30621/jbachs.2020.1283
19. Coussens AK. The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease. Photochem Photobiol Sci. 2017;16:314–338. doi:10.1039/c6pp00355a
20. Lang PO, Aspinall R. Vitamin D status and the host resistance to infections: what it is currently (not) understood. Clin Ther. 2017;39(5):930–945. doi:10.1016/j. clinthera.2017.04.004
21. Gruber-Bzura BM. Vitamin D and influenza—prevention or therapy?Int J Mol Sci. 2018;19:2419.
22. Gombart AF, Pierre A, Maggini SA. Review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients. 2020;12(1):236. doi:10.3390/nu12010236
23. Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988. doi:10.3390/nu12040988
24. Autier P, Mullie P, Macacu A, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabet Endocrinol. 2017;5(12):986–1004. doi:10.1016/S2213-8587(17)30357-1
25. Rejnmark L, Bislev LS, Cashman KD, et al. Non-skeletal health effects of vitamin D supplementation: a systematic review on findings from meta-analyses summarizing trial data. PLoS ONE. 2017;12(7):e0180512. doi:10.1371/journal.pone.0180512
26. Bergman P, Lindh ÅU, Björkhem-Bergman L, et al. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2013;8(6):e65835. doi:10.1371/journal.pone.0065835
27. Charan J, Goyal J, Saxena D, et al. Vitamin D for prevention of respiratory tract infections: a systematic review and meta-analysis. J Pharmacol Pharmacother. 2012;3(4):300–303. doi:10.4103/0976-500X.103685
28. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017; 356:i6583.
29. Ali A. Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health. 2020;13(10):1373–1380. doi:10.1016/j. jiph.2020.06.021
30. Miles EA, Calder PC. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr. 2012;107(S2):S171– S184. doi:10.1017/S0007114512001560
31. Yang B, Ren X-L, Li Z-H, et al. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial. Food Funct. 2020;11(2):1779–1789. doi:10.1039/c9fo03085a
32. Moens E, Veldhoen M. Epithelial barrier biology: good fences make good neighbours. Immunology. 2012;135(1):1–8. doi:10.1111/j.1365-2567.2011.03506.x
33. Wu Y, Guo C, Tang L, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 2020;1253(20):20–21.
34. Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514– 523. doi:10.1016/S0140-6736(20)30154-9 Dhara D, Mohanty A. Gut microbiota and Covid-19- possible link and implications. Virus Res. 2020;285.
35. World Health Organization. 2020. http://www.emro.who. int/nutrition/nutrition-infocus/nutrition-advic e-for-adults-during-the-covid-19-outbreak.html.
36. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–500. doi:10.1016/ S0140-6736(20)30183-5
37. Volkert D, Beck AM, Cederholm T, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr. 2019;38(1):10–47. doi:10.1016/j.clnu.2018.05.024
38. Gomes F, Schuetz P, Bounoure L, et al. ESPEN guidelines on nutritional support for polymorbid internal medicine patients. Clin Nutr. 2018;37(1):336–353. doi:10.1016/j.clnu.2017.06.025
39. Barazzoni R, Bischoff SC, Breda J, et al. Endorsed by the ESPEN Council. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. 2020;39(6):1631–1638. doi:10.1016/j.clnu.2020.03.022
40. Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48–79. doi:10.1016/j.clnu.2018.08.037
41. Terzi N, Darmon M, Reignier J, et al. Initial nutritional management during noninvasive ventilation and outcomes: a retrospective cohort study. Crit Care. 2017;21(1):293. doi:10.1186/s13054-017-1867-y
42. Peterson SJ, Tsai AA, Scala CM, et al. Adequacy of oral intake in critically ill patients 1 week after extubation. J Am Diet Assoc. 2010;110(3):427e33–433. doi:10.1016/j. jada.2009.11.020
43. Skoretz SA, Flowers HL, Martino R. The incidence of dysphagia following endotracheal intubation: a systematic review. Chest. 2010;137(3):665–673. doi:10.1378/chest.09-1823